RVT-101 70 mg

DRUG2 trials

Sponsors

Axovant Sciences Ltd.

Conditions

Dementia With Lewy Bodies

Phase 2

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

CompletedNCT02669433

Axovant Sciences Ltd.Dementia With Lewy Bodies

Start: 2016-01-31End: 2017-12-31Updated: 2019-04-26

Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

TerminatedNCT02928445

Axovant Sciences Ltd.Dementia With Lewy Bodies

Start: 2016-10-31End: 2018-02-28Target: 240Updated: 2018-04-18